Annual CFF
-$1.87 M
-$14.25 M-115.12%
December 31, 2022
Summary
- As of March 10, 2025, BIOC annual cash flow from financing activities is -$1.87 million, with the most recent change of -$14.25 million (-115.12%) on December 31, 2022.
- During the last 3 years, BIOC annual CFF has fallen by -$31.53 million (-106.31%).
Performance
BIOC Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
$2.97 M
+$2.81 M+1731.48%
June 30, 2023
Summary
- As of March 10, 2025, BIOC quarterly cash flow from financing activities is $2.97 million, with the most recent change of +$2.81 million (+1731.48%) on June 30, 2023.
- Over the past year, BIOC quarterly CFF has stayed the same.
Performance
BIOC Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
$1.91 M
+$3.35 M+232.34%
June 30, 2023
Summary
- As of March 10, 2025, BIOC TTM cash flow from financing activities is $1.91 million, with the most recent change of +$3.35 million (+232.34%) on June 30, 2023.
- Over the past year, BIOC TTM CFF has stayed the same.
Performance
BIOC TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
BIOC Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -115.1% | 0.0% | 0.0% |
| 3 y3 years | -106.3% | 0.0% | 0.0% |
| 5 y5 years | -110.1% | 0.0% | 0.0% |
BIOC Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -115.1% | at low | at high | -125.1% | -84.6% | -198.1% |
| 5 y | 5-year | -106.3% | at low | -83.0% | -125.1% | -94.6% | -198.1% |
| alltime | all time | -106.3% | at low | -83.0% | -126.2% | -94.6% | -198.1% |
Biocept Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $2.97 M(+1731.5%) | $1.91 M(-232.3%) |
| Mar 2023 | - | $162.00 K(-121.7%) | -$1.44 M(-23.0%) |
| Dec 2022 | -$1.87 M(-115.1%) | -$746.00 K(+56.7%) | -$1.87 M(+100.5%) |
| Sep 2022 | - | -$476.00 K(+24.9%) | -$933.00 K(-110.8%) |
| Jun 2022 | - | -$381.00 K(+42.2%) | $8.63 M(-30.5%) |
| Mar 2022 | - | -$268.00 K(-239.6%) | $12.41 M(+0.3%) |
| Dec 2021 | $12.38 M(-51.9%) | $192.00 K(-97.9%) | $12.38 M(+6.7%) |
| Sep 2021 | - | $9.08 M(+166.6%) | $11.60 M(+461.4%) |
| Jun 2021 | - | $3.41 M(-1227.8%) | $2.07 M(-73.9%) |
| Mar 2021 | - | -$302.00 K(-48.4%) | $7.93 M(-69.2%) |
| Dec 2020 | $25.72 M(-13.3%) | -$585.00 K(+29.2%) | $25.72 M(-26.5%) |
| Sep 2020 | - | -$452.70 K(-104.9%) | $34.98 M(-0.6%) |
| Jun 2020 | - | $9.27 M(-47.0%) | $35.20 M(+15.3%) |
| Mar 2020 | - | $17.49 M(+101.7%) | $30.53 M(+2.9%) |
| Dec 2019 | $29.66 M(+24.8%) | $8.67 M(-3832.8%) | $29.66 M(+42.1%) |
| Sep 2019 | - | -$232.30 K(-105.0%) | $20.88 M(-36.8%) |
| Jun 2019 | - | $4.60 M(-72.3%) | $33.02 M(+19.5%) |
| Mar 2019 | - | $16.62 M(<-9900.0%) | $27.64 M(+16.2%) |
| Dec 2018 | $23.78 M(+27.9%) | -$114.60 K(-101.0%) | $23.78 M(-9.4%) |
| Sep 2018 | - | $11.91 M(-1630.1%) | $26.26 M(+67.2%) |
| Jun 2018 | - | -$778.70 K(-106.1%) | $15.70 M(-13.0%) |
| Mar 2018 | - | $12.76 M(+439.0%) | $18.04 M(-2.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $18.59 M(+55.7%) | $2.37 M(+74.5%) | $18.59 M(-24.6%) |
| Sep 2017 | - | $1.36 M(-13.4%) | $24.65 M(+6.0%) |
| Jun 2017 | - | $1.57 M(-88.2%) | $23.25 M(-8.6%) |
| Mar 2017 | - | $13.30 M(+57.8%) | $25.44 M(+113.1%) |
| Dec 2016 | $11.94 M(-36.4%) | $8.43 M(<-9900.0%) | $11.94 M(+191.8%) |
| Sep 2016 | - | -$42.00 K(-101.1%) | $4.09 M(+4.7%) |
| Jun 2016 | - | $3.75 M(-1965.2%) | $3.91 M(+202.8%) |
| Mar 2016 | - | -$201.00 K(-134.4%) | $1.29 M(-93.1%) |
| Dec 2015 | $18.78 M(-7.3%) | $584.40 K(-360.1%) | $18.78 M(+3.5%) |
| Sep 2015 | - | -$224.70 K(-119.8%) | $18.15 M(-1.1%) |
| Jun 2015 | - | $1.13 M(-93.5%) | $18.36 M(-17.0%) |
| Mar 2015 | - | $17.29 M(<-9900.0%) | $22.11 M(+9.1%) |
| Dec 2014 | $20.27 M(+232.9%) | -$43.50 K(+168.5%) | $20.27 M(-5.3%) |
| Sep 2014 | - | -$16.20 K(-100.3%) | $21.40 M(-9.1%) |
| Jun 2014 | - | $4.88 M(-68.4%) | $23.55 M(+18.3%) |
| Mar 2014 | - | $15.44 M(+1314.6%) | $19.91 M(+227.1%) |
| Dec 2013 | $6.09 M(-27.2%) | $1.09 M(-48.7%) | $6.09 M(+21.9%) |
| Sep 2013 | - | $2.13 M(+70.6%) | $5.00 M(+74.3%) |
| Jun 2013 | - | $1.25 M(-22.8%) | $2.87 M(+77.2%) |
| Mar 2013 | - | $1.62 M | $1.62 M |
| Dec 2012 | $8.37 M(-18.0%) | - | - |
| Dec 2011 | $10.21 M | - | - |
FAQ
- What is Biocept annual cash flow from financing activities?
- What is the all time high annual CFF for Biocept?
- What is Biocept annual CFF year-on-year change?
- What is Biocept quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Biocept?
- What is Biocept quarterly CFF year-on-year change?
- What is Biocept TTM cash flow from financing activities?
- What is the all time high TTM CFF for Biocept?
- What is Biocept TTM CFF year-on-year change?
What is Biocept annual cash flow from financing activities?
The current annual CFF of BIOC is -$1.87 M
What is the all time high annual CFF for Biocept?
Biocept all-time high annual cash flow from financing activities is $29.66 M
What is Biocept annual CFF year-on-year change?
Over the past year, BIOC annual cash flow from financing activities has changed by -$14.25 M (-115.12%)
What is Biocept quarterly cash flow from financing activities?
The current quarterly CFF of BIOC is $2.97 M
What is the all time high quarterly CFF for Biocept?
Biocept all-time high quarterly cash flow from financing activities is $17.49 M
What is Biocept quarterly CFF year-on-year change?
Over the past year, BIOC quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Biocept TTM cash flow from financing activities?
The current TTM CFF of BIOC is $1.91 M
What is the all time high TTM CFF for Biocept?
Biocept all-time high TTM cash flow from financing activities is $35.20 M
What is Biocept TTM CFF year-on-year change?
Over the past year, BIOC TTM cash flow from financing activities has changed by $0.00 (0.00%)